Search research articles
Contact Us
Filters
Showing results (331-340 of 342) with videos related to
Page
of 35
Sort By:
The Journal of Molecular Diagnostics : JMD
|
January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes
Carmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Cancer Investigation
|
October 30, 2009
Expression of progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line
R Cuevas-Antonio, C Cancino, F Arechavaleta-Velasco, et al.
ACS Chemical Neuroscience
|
August 26, 2017
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X<sub>7</sub> Receptor Antagonist
Shane M Wilkinson, Melissa L Barron, James O'Brien-Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1997
Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
M W Becher, D C Rubinsztein, J Leggo, et al.
Blood
|
December 4, 2008
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
Katherine I Lin, Constantine S Tam, Michael J Keating, et al.
Blood
|
February 12, 2011
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients
Hatice Duzkale, Carmen D Schweighofer, Kevin R Coombes, et al.
Leukemia Research
|
November 26, 2008
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene
Shelly R Gunn, Aswani R Bolla, Lynn L Barron, et al.
Mucosal Immunology
|
December 26, 2013
The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells
F Meylan, E T Hawley, L Barron, et al.
The Lancet. Oncology
|
October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
Carmen D Herling, Kevin R Coombes, Axel Benner, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 14, 2025
Automated Label-Free Assay for Viral Detection and Inhibitor Screening via Biomembrane-Functionalized Microelectrode Arrays
Zixuan Lu, Jeremy Treiber, Konstantinos Kallitsis, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 342) with videos related to
Sort By:
Page
of 35
The Journal of Molecular Diagnostics : JMD
|
January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes
Carmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.
Cancer Investigation
|
October 30, 2009
Expression of progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line
R Cuevas-Antonio, C Cancino, F Arechavaleta-Velasco, et al.
ACS Chemical Neuroscience
|
August 26, 2017
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X<sub>7</sub> Receptor Antagonist
Shane M Wilkinson, Melissa L Barron, James O'Brien-Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1997
Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
M W Becher, D C Rubinsztein, J Leggo, et al.
Blood
|
December 4, 2008
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
Katherine I Lin, Constantine S Tam, Michael J Keating, et al.
Blood
|
February 12, 2011
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients
Hatice Duzkale, Carmen D Schweighofer, Kevin R Coombes, et al.
Leukemia Research
|
November 26, 2008
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene
Shelly R Gunn, Aswani R Bolla, Lynn L Barron, et al.
Mucosal Immunology
|
December 26, 2013
The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells
F Meylan, E T Hawley, L Barron, et al.
The Lancet. Oncology
|
October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
Carmen D Herling, Kevin R Coombes, Axel Benner, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
August 14, 2025
Automated Label-Free Assay for Viral Detection and Inhibitor Screening via Biomembrane-Functionalized Microelectrode Arrays
Zixuan Lu, Jeremy Treiber, Konstantinos Kallitsis, et al.
Page
of 35